Neprilysininhibitor The intricate interplay between neprilysin and natriuretic peptides is a cornerstone of cardiovascular regulation. Neprilysin, a neutral endopeptidase, is recognized as a fundamental enzyme responsible for degrading various vasoactive peptidesNeprilysin and Natriuretic Peptide Regulation in Heart Failure. Among its critical substrates are the natriuretic peptides (NPs), a family of hormones that play a vital role in maintaining cardiovascular homeostasis. Understanding the function and regulation of neprilysin and natriuretic peptides is crucial, especially in the context of cardiovascular diseases like heart failure (HF).作者:E D'Elia·2017·被引用次数:196—Neprilysin catalyses the degradation of a number of vasodilator peptides, including the natriuretic peptides, bradykinin, substance P, and ...
Neprilysin (NEP) is a transmembrane enzyme with a broad substrate specificity. Its primary function within the cardiovascular system is to break down numerous vasoactive peptides, effectively terminating their biological actions. This includes the degradation of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP). Neprilysin also cleaves other important vasoactive substances such as bradykinin, substance P, and constituents of the renin-angiotensin system.
The precise mechanism of neprilysin action involves cleaving active forms of A- and B-type natriuretic peptides (ANP and BNP)作者:EM Selezneva·2025—Neprilysin (NEP) cleaves active forms of A- and B-type natriuretic peptides(ANP and BNP) at multiple sites, reducing their compensatory .... This cleavage effectively reduces their circulating levels and consequently their beneficial compensatory effects. For instance, studies have indicated that neprilysin has a higher affinity for ANP and CNP compared to BNP. It's important to note that proBNP and N-terminal proBNP are not degraded by neprilysin作者:MK Jangid·被引用次数:7—This review provides an overview ofhow natriuretic peptides (NPs) contribute to blood pressure regulationfor the treatment of hypertension through inhibiting ....
Natriuretic peptides are a family of cyclic peptide hormones with significant physiological rolesB-Type Natriuretic Peptide Testing in the Era of Neprilysin .... They are key regulators of blood volume, natriuresis (sodium excretion), and vasodilation, acting as natural antagonists to the renin-angiotensin-aldosterone system. The primary members of this family include:
* Atrial Natriuretic Peptide (ANP): Primarily released from the atria of the heart in response to atrial stretch.作者:H Nakagawa·2022·被引用次数:22—Neprilysin(NEP) is a transmembrane neutral endopeptidase that degrades the threenatriuretic peptides. Recently, mice overexpressing NEP, ... It promotes vasodilation and sodium and water excretionNeprilysin expression and functions in development, ageing and disease.
* Brain Natriuretic Peptide (BNP): Primarily synthesized and secreted by the ventricles of the heart in response to ventricular stretch.作者:A Bayes-Genis·2016·被引用次数:43—Neprilysin is acknowledged as a key player in neurohormonal regulation, a cornerstone of modern drug therapy in chronic heart failure. BNP plays a critical role in the body's response to increased cardiac filling pressures.作者:EM Selezneva·2025—Neprilysin (NEP) cleaves active forms of A- and B-type natriuretic peptides(ANP and BNP) at multiple sites, reducing their compensatory ... Elevated plasma B-type natriuretic peptide (BNP) concentrations are a well-established indicator of cardiac stress and dysfunction.
* C-type Natriuretic Peptide (CNP): Primarily found in the vascular endothelium and plays a role in local vascular tone regulation.作者:N Vasquez·2020·被引用次数:25—The purpose of this review is to describe the effects of angiotensin receptorneprilysininhibitor (ARNI) therapy on thenatriuretic peptideaxis (NPA).
These peptides are essential for maintaining cardiovascular balance作者:NE Ibrahim·2019·被引用次数:153—Neprilysin is an endopeptidase that is responsible for the breakdown of numerous vasoactive peptides (atrial natriuretic peptide [ANP], pro-ANP .... Their actions contribute to lowering blood pressure and reducing the workload on the heart.
Given that neprilysin is responsible for breaking down these beneficial natriuretic peptides, inhibiting its activity has emerged as a significant therapeutic strategy. Neprilysin inhibition leads to increased circulating levels of natriuretic peptides, thereby augmenting their protective effects. This approach has become a focus of considerable interest in cardiology, particularly for the management of heart failure (HF).
One of the most notable advancements in this field is the development of angiotensin receptor-neprilysin inhibitors (ARNI), such as the combination of sacubitril/valsartan.作者:NE Ibrahim·2019·被引用次数:153—Neprilysin is an endopeptidase that is responsible for the breakdown of numerous vasoactive peptides (atrial natriuretic peptide [ANP], pro-ANP ... In this therapy, sacubitril acts as the neprilysin inhibitor, while valsartan is an angiotensin receptor blocker (ARB). By blocking neprilysin, sacubitril enhances the levels of natriuretic peptides and other beneficial peptides, while the ARB component counteracts the effects of angiotensin II. This dual mechanism of action has demonstrated impressive benefits in patients with chronic heart failureNeprilysin 2 catalyses the degradation of natriuretic ....
The efficacy of neprilysin inhibition in heart failure is underpinned by its ability to augment the activity of natriuretic peptides. These peptides contribute to blood pressure regulation, diuresis, and vasodilation, all of which are beneficial in reducing cardiac strain and improving symptoms in patients with HF. The natriuretic peptide axis (NPA) is thus favorably modulated by neprilysin inhibition.
In fact, elevated BNP levels in patients with heart failure can act as an endogenous neprilysin inhibitor, suggesting a feedback mechanism within the neurohormonal system作者:JL Januzzi Jr·2016·被引用次数:11—Neprilysin is a neutral endopeptidasethat is responsible for the degradation of several endogenous vasoactive substances, including natriuretic .... The utility of natriuretic peptides to assess and manage patients with heart failure receiving such therapies is also paramount, as they serve as important diagnostic and prognostic biomarkers.
The role of neprilysin extends beyond heart failure.作者:K Ding·2022·被引用次数:9—The natriuretic peptide (NP) family of proteinsregulates blood volume, natriuresis, and vasodilationand can antagonize the renin-angiotensin- ... Its involvement in neurohormonal regulation makes it a key player in managing various cardiovascular conditions. Furthermore, the neprilysin pathway is intricate, involving numerous vasoactive substances. The understanding of neprilysin: function and its interaction with natriuretic peptides impacts therapeutic strategies for conditions such as hypertension. Research continues into the various neprilysin substrates and their roles in physiological and pathological processes.Neprilysin and Natriuretic Peptide Regulation in Heart Failure
The advent of neprilysin inhibitors has also opened new avenues for understanding soluble neprilysin as a potential new biomarker in acute and chronic HF.作者:E D'Elia·2017·被引用次数:196—Neprilysin catalyses the degradation of a number of vasodilator peptides, including the natriuretic peptides, bradykinin, substance P, and ... Monitoring circulating neprilysin activity may offer further insights into disease progression and therapeutic responseRoles of Natriuretic Peptides and the Significance .... As research progresses, the exploration of novel neprilysin inhibitor drugs and a deeper understanding of how to increase neprilysin-mediated effects therapeutically will continue to shape cardiovascular medicine.
In conclusion, the relationship between neprilysin and natriuretic peptides is a critical component of cardiovascular health. Neprilysin acts as a primary degrader of these vital peptides, and inhibiting this enzyme has proven to be a life-saving approach, particularly in the management of heart failureNeprilysin | Inhibitors. The ongoing research into neprilysin and its inhibitors promises further advancements in treating cardiovascular diseases, highlighting the profound impact of understanding these molecular interactions.
Join the newsletter to receive news, updates, new products and freebies in your inbox.